China price cap regulations in the pipeline, but US industry looks at options
This article was originally published in Clinica
China is planning to regulate medical device pricing, according to new guidelines that will cap the price of medicines at 15% above their purchase price for non-profit health providers, such as hospitals.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.